KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Date Action Amount Person Type
Dec 15, 2023 Buy 1 300 000 Matkovits Theresa Stock Option (right to Buy)
Dec 15, 2023 Buy 1 000 000 Hoover Thomas Stock Option (right to Buy)
Dec 15, 2023 Buy 1 000 000 Kucinski Keith A Stock Option (right to Buy)
Dec 15, 2023 Buy 1 000 000 Liu Hui Stock Option (right to Buy)
Dec 15, 2023 Buy 3 500 000 Jabbour Jerome D Stock Option (right to Buy)
Dec 15, 2023 Buy 1 200 000 Ferguson James J. Iii Stock Option (right to Buy)
Nov 01, 2023 Buy 437 244 Ende Eric J Stock option (right to buy)
Nov 01, 2023 Buy 437 244 Corzo Kathryn Penkus Stock option (right to buy)
Nov 01, 2023 Buy 437 244 Wikler Matthew Stock option (right to buy)
Nov 01, 2023 Buy 437 244 Conrad Herbert J Stock option (right to buy)
Nov 01, 2023 Buy 437 244 Scibetta James S Stock option (right to buy)
Nov 01, 2023 Buy 437 244 Giordano Natasha Stock option (right to buy)
Dec 20, 2022 Buy 625 000 Matkovits Theresa Stock Option (right to Buy)
Dec 20, 2022 Buy 625 000 Liu Hui Stock Option (right to Buy)
Dec 20, 2022 Buy 625 000 Kucinski Keith A Stock Option (right to Buy)
Dec 20, 2022 Buy 1 988 300 Jabbour Jerome D Stock Option (right to Buy)
Dec 20, 2022 Buy 475 000 Hoover Thomas Stock Option (right to Buy)
Dec 20, 2022 Buy 625 000 Ferguson James J. Iii Stock Option (right to Buy)
Nov 14, 2022 Buy 142 657 Giordano Natasha Stock option (right to buy)
Nov 14, 2022 Buy 142 657 Corzo Kathryn Penkus Stock option (right to buy)
Nov 14, 2022 Buy 142 657 Conrad Herbert J Stock option (right to buy)
Nov 14, 2022 Buy 142 657 Wikler Matthew Stock option (right to buy)
Nov 14, 2022 Buy 142 657 Ende Eric J Stock option (right to buy)
Nov 14, 2022 Buy 142 657 Scibetta James S Stock option (right to buy)
Jun 22, 2022 Buy 1 358 122 Conrad Herbert J Common Stock, par value $0.0001 per share
Jun 22, 2022 Sell 1 358 122 Conrad Herbert J Common Stock, par value $0.0001 per share
Dec 31, 2021 Buy 7 859 Wikler Matthew Common Stock
Dec 14, 2021 Buy 1 658 100 Jabbour Jerome D Stock Option (right to Buy)
Dec 14, 2021 Buy 500 000 Kucinski Keith A Stock Option (right to Buy)
Dec 14, 2021 Buy 275 000 Hui Liu Stock Option (right to Buy)
Dec 14, 2021 Buy 275 000 Mannino Raphael J Stock Option (right to Buy)
Dec 14, 2021 Buy 500 000 Matkovits Theresa Stock Option (right to Buy)
Dec 14, 2021 Buy 587 600 Ferguson James J. Iii Stock Option (right to Buy)
Dec 14, 2021 Buy 850 000 Hoover Thomas Stock Option (right to Buy)
Dec 06, 2021 Buy 0 Hoover Thomas
Nov 01, 2021 Buy 90 882 Giordano Natasha Stock option (right to buy)
Nov 01, 2021 Buy 90 882 Wikler Matthew Stock option (right to buy)
Nov 01, 2021 Buy 90 882 Scibetta James S Stock option (right to buy)
Nov 01, 2021 Buy 90 882 Conrad Herbert J Stock option (right to buy)
Nov 01, 2021 Buy 90 882 Ende Eric J Stock option (right to buy)
Nov 01, 2021 Buy 181 763 Corzo Kathryn Penkus Stock option (right to buy)
Nov 01, 2021 Buy 0 Corzo Kathryn Penkus
Sep 30, 2021 Buy 6 106 Wikler Matthew Common Stock
Sep 03, 2021 Buy 462 150 Mannino Raphael J Common Stock, par value $0.0001 per share
Aug 04, 2021 Buy 494 622 Conrad Herbert J Common Stock, par value $0.0001 per share
Jul 07, 2021 Buy 1 280 917 Conrad Herbert J Common Stock, par value $0.0001 per share
Jul 07, 2021 Sell 1 280 917 Conrad Herbert J Common Stock, par value $0.0001 per share
Jun 30, 2021 Buy 10 244 Wikler Matthew Common Stock
Jun 19, 2021 Buy 24 000 Ende Eric J Common Stock, par value $0.0001 per share
Jun 19, 2021 Buy 4 800 Ende Eric J Common Stock, par value $0.0001 per share
Jun 19, 2021 Sell 12 Ende Eric J Series B Preferred Stock
Jun 19, 2021 Buy 30 000 Jabbour Jerome D Common Stock, par value $0.0001 per share
Jun 19, 2021 Buy 6 000 Jabbour Jerome D Common Stock, par value $0.0001 per share
Jun 19, 2021 Sell 15 Jabbour Jerome D Series B Preferred Stock
Jun 19, 2021 Buy 24 000 Scibetta James S Common Stock, par value $0.0001 per share
Jun 19, 2021 Buy 4 800 Scibetta James S Common Stock, par value $0.0001 per share
Jun 19, 2021 Sell 12 Scibetta James S Series B Preferred Stock
Jun 19, 2021 Buy 12 000 Wikler Matthew Common Stock, par value $0.0001 per share
Jun 19, 2021 Buy 2 400 Wikler Matthew Common Stock, par value $0.0001 per share
Jun 19, 2021 Sell 6 Wikler Matthew Series B Preferred Stock
Jun 19, 2021 Buy 200 000 Conrad Herbert J Common Stock, par value $0.0001 per share
Jun 19, 2021 Buy 40 000 Conrad Herbert J Common Stock, par value $0.0001 per share
Jun 19, 2021 Sell 100 Conrad Herbert J Series B Preferred Stock
Jun 19, 2021 Buy 20 000 Mannino Raphael J Common Stock, par value $0.0001 per share
Jun 19, 2021 Buy 8 000 Mannino Raphael J Common Stock, par value $0.0001 per share
Jun 19, 2021 Sell 10 Mannino Raphael J Series B Preferred Stock
May 20, 2021 Buy 1 145 905 Conrad Herbert J Common Stock, par value $0.0001 per share
May 20, 2021 Sell 1 145 905 Conrad Herbert J Common Stock, par value $0.0001 per share
Mar 31, 2021 Buy 7 560 Wikler Matthew Common Stock
Jan 13, 2021 Sell 50 000 Conrad Herbert J Common Stock, par value $0.0001 per share
Jan 13, 2021 Buy 50 000 Conrad Herbert J Common Stock, par value $0.0001 per share
Jan 13, 2021 Buy 100 Conrad Herbert J Series B Convertible Preferred Stock
Jan 13, 2021 Sell 100 Conrad Herbert J Series B Convertible Preferred Stock
Jan 01, 2021 Buy 425 000 Matkovits Theresa Stock option (right to buy)
Jan 01, 2021 Buy 200 000 Mannino Raphael J Stock option (right to buy)
Jan 01, 2021 Buy 250 000 Hui Liu Stock option (right to buy)
Jan 01, 2021 Buy 1 600 000 Jabbour Jerome D Stock option (right to buy)
Jan 01, 2021 Buy 500 000 Kucinski Keith A Stock option (right to buy)
Jan 01, 2021 Buy 575 000 Ferguson James J. Iii Stock option (right to buy)
Dec 31, 2020 Buy 11 673 Wikler Matthew Common Stock
Dec 01, 2020 Buy 350 000 Hui Liu Stock option (right to buy)
Dec 01, 2020 Buy 0 Hui Liu
Nov 02, 2020 Buy 122 605 Lepore Patrick G Stock option (right to buy)
Nov 02, 2020 Buy 122 605 Scibetta James S Stock option (right to buy)
Nov 02, 2020 Buy 122 605 Conrad Herbert J Stock option (right to buy)
Nov 02, 2020 Buy 122 605 Wikler Matthew Stock option (right to buy)
Nov 02, 2020 Buy 122 605 Ende Eric J Stock option (right to buy)
Sep 30, 2020 Buy 20 725 Wikler Matthew Common Stock
Sep 14, 2020 Buy 287 917 Giordano Natasha Option (right to buy)
Aug 21, 2020 Buy 20 000 Stern Adam K Common Stock, par value $0.0001 per share
Jun 30, 2020 Buy 20 537 Wikler Matthew Common Stock
Jun 23, 2020 Buy 30 000 Conrad Herbert J Common Stock, par value $0.0001 per share
Jun 23, 2020 Buy 4 500 Jabbour Jerome D Common Stock, par value $0.0001 per share
Jun 23, 2020 Buy 1 800 Wikler Matthew Common Stock, par value $0.0001 per share
Jun 23, 2020 Buy 3 600 Ende Eric J Common Stock, par value $0.0001 per share
Jun 23, 2020 Buy 3 000 Mannino Raphael J Common Stock, par value $0.0001 per share
Jun 23, 2020 Buy 3 600 Scibetta James S Common Stock, par value $0.0001 per share
Jun 23, 2020 Buy 25 500 Stern Adam K Common Stock, par value $0.0001 per share
Jun 17, 2020 Buy 500 000 Jabbour Jerome D Stock option (right to buy)
Jun 17, 2020 Buy 175 000 Matkovits Theresa Stock option (right to buy)
INSIDER POWER
80.153
Last 100 transactions
Buy: 33 545 041 | Sell: 3 835 199 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 80.153.

In total, the insiders bought 33 545 041 and sold 3 835 199 MTNB shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Matinas Biopharma Holdings Inc

Matinas Biopharma Holdings Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is LYPDISO, a presc... MTNB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT